Nobutaka Hattori Selected Research

Parkinson Disease (Parkinson's Disease)

08/2008	Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease.
01/2008	Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literature.
08/2007	[Relationship between alpha-synuclein and Parkinson's disease]
08/2007	Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease.
06/2007	Fibroblast growth factor 20 gene and Parkinson's disease in the Japanese population.
02/2007	Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population.
10/2006	Nuclear localization of the 20S proteasome subunit in Parkinson's disease.
09/2006	Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.
08/2006	Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
08/2006	Up-regulation of hMUTYH, a DNA repair enzyme, in the mitochondria of substantia nigra in Parkinson's disease.
04/2006	Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.
02/2006	Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
11/2005	[Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation]
05/2005	Phosphorylated IkappaBalpha is a component of Lewy body of Parkinson's disease.
03/2005	Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease.
03/2005	Expression of 8-oxoguanine DNA glycosylase (OGG1) in Parkinson's disease and related neurodegenerative disorders.
12/2003	Appropriate dosing of pergolide in monotherapy and adjunctive therapy in Parkinson's disease.
01/2003	Haploinsufficiency at the alpha-synuclein gene underlies phenotypic severity in familial Parkinson's disease.
11/2002	Golden mean to longevity: rareness of mitochondrial cytochrome b variants in centenarians but not in patients with Parkinson's disease.

Articles by Research Topic

Disease

19	Parkinson Disease (Parkinson's Disease) 08/2008 - 11/2002
1	Ischemia 07/2008
1	Parkinsonian Disorders (Parkinsonism) 06/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2005
1	Atherosclerosis (Atheroma) 04/2004
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 08/2002

Drug/Important Bio-Agent (IBA)

8	alpha-SynucleinIBA 08/2008 - 01/2003
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 08/2008 - 06/2007
2	Leucine (L-Leucine)FDA Link 02/2007 - 09/2006
2	Phosphotransferases (Kinase)IBA 02/2007 - 09/2006
1	calbindinIBA 08/2008
1	Type 2 Angiotensin ReceptorIBA 07/2008
1	Amantadine (Aman)FDA LinkGeneric 01/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2007
1	pigment epithelium-derived factorIBA 08/2007
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2006
1	A-Form DNA (A-DNA)IBA 08/2006
1	NF-kappaB inhibitor alphaIBA 05/2005
1	8-hydroxy-2'-deoxyguanosineIBA 03/2005
1	8-hydroxyguanineIBA 03/2005
1	DNA Glycosylases (DNA Glycosylase)IBA 03/2005
1	Mitochondrial DNA (mtDNA)IBA 04/2004
1	Pergolide (Permax)FDA Link 12/2003
1	Cytochromes b (Cytochrome b)IBA 11/2002
1	Messenger RNA (mRNA)IBA 08/2002
1	Protein Isoforms (Isoforms)IBA 08/2002